Hudson Bay Capital Management LP Grows Stock Holdings in Kymera Therapeutics, Inc. $KYMR
Hudson Bay Capital Management LP grew its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 362.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 23,134 shares of the company's stock after buying an additional 18...